Clive Hamlin, PhD

Associate Professor Emeritus
Department of Pathology
School of Medicine

Dr. Clive Hamlin received his B.S. in Chemistry and Physics from the University of London, United Kingdom, in 1961. He also went on to earn his M.S. in Chemistry. In 1967, Dr. Hamlin earned a Ph.D. in Biochemistry from the University of Waterloo, Canada. He spent the next few years as a Postdoctoral Fellow in Biochemistry at the University of Waterloo and the University of Rochester, and in Experimental Pathology at CWRU and University Hospitals of Cleveland. Dr. Hamlin spent some time as an Instructor at CWRU's Institute of Pathology, and went on to be the Director of Clinical Chemistry from 1970 until 1995. During that time he was also an Assistant Professor in Experimental Pathology (1972-1982) and the Trustee and Director of University Medical Laboratories (1984-1995). Presently, his positions include Associate Professor of Pathology at CWRU (1982-), Laboratory Director at University Suburban Health Center (1985-), and Laboratory Director of the National Prion Disease Pathology Surveillance Center (2001-).

Research Information

Research Interests

  • Clinical pathology, with particular interest in prion disease testing.

Publications

View All Publications

Hamlin CR (1999). Performance characteristics of the TOSOH Alc 2.2 plus analyzer in the quantification of hemoglobin Alc. Clin Chem Lab Med 37, 5385.

Pretlow TG, Schwartz S, Giaconia JK, Wright AL, Grimm HA, Edgehouse NL, Murphy JR, Markowitz SD, Jamison JM, Summers JL, Hamlin CR, MacLennan GT, Resnick MI, Pretlow, TP and Connell CF (2000). Prostate cancer and other xenografts from cells in peripheral blood of patients. Canc Res 60, 4033-4036.

Hamlin CR, Medof ME (2000). Further studies on urinary decay - accelerating factor and CD59. Ann Clin Sci 30, 316-317.

Hamlin CR (2001). Modifications to improve the sensitivity of a routine estradiol assay. Ann Clin Sci 31, 307-308.

Hamlin CR (2001). A sensitive estradiol assay performed on the Bayer ACS-180 Immunoanalyzer. Proceedings of the 14th IFCC European Congress of Clinical Chemistry, Prague, Czech Republic, 251.

Education

Degree
Doctor of Philosophy
Institution
University of Waterloo, Canada
Area of Study
Biochemistry
Degree
Master of Science
Institution
University of London
Area of Study
Chemistry
Degree
Bachelor of Science
Institution
University of London
Area of Study
Chemistry and Physics

Residencies, Internships and Fellowships

Institution
University of Waterloo
Area of Study
Postdoctoral Fellowship in Biochemistry
Institution
University of Rochester
Area of Study
Postdoctoral Fellowship in Biochemistry
Institution
Case Western Reseve University
Area of Study
Postdoctor Fellowship in Experimental Pathology
Institution
University Hospitals of Cleveland
Area of Study
Postdoctor Fellowship in Experimental Pathology